FIELD: medicine.
SUBSTANCE: invention relates to the prevention of infectious diseases and can be used to prevent influenza infection. The method involves intranasal administration in a physiological solution of a copolymer of vinylphosphonic acid with 4-acryloylmorpholine (VPA-4-AM), containing 35–70 mol.% vinylphosphonic acid, with a molecular weight of (20–70)⋅103, at a copolymer concentration of 300 μg/ml in a solution volume of 30 μl.
EFFECT: use of the invention allows for nonspecific prevention of influenza infection when applied topically.
1 cl, 2 dwg, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| WATER-SOLUBLE COPOLYMERS OF VINYLPHOSPHONIC ACID | 2022 |
|
RU2788168C1 |
| SUBTYPE H1N1 INFLUENZA VIRUS STRAIN A/RUSSIA/OL/2009-MA FOR STUDY OF THERAPEUTIC AND PREVENTIVE ACTIVITY OF ANTIVIRAL PREPARATIONS in vitro AND in vivo | 2010 |
|
RU2451072C1 |
| 6,13,13-TRIMETHYL-6,8,9,12-TETRAHYDRO-6,9-METHANOSEPINO[2,1-B]HINAZOLIN-10(7H)-ONE AS THE INHIBITOR OF INFLUENZA VIRUSES | 2017 |
|
RU2664331C1 |
| COMPOUND 6,8-DIFLUORO-2-(4-(TRIFLUOROMETHYL)PHENYL)CHROMAN-4-ONE AS INHIBITOR OF REPRODUCTION OF INFLUENZA A AND B VIRUSES AND METHOD FOR PRODUCTION THEREOF | 2023 |
|
RU2826250C1 |
| STRAIN A/Salekhard/01/2009(H1N1)v OF SUBTYPE H1N1 INFLUENZA A VIRUS FOR STUDYING THERAPEUTIC AND PROPHYLACTIC EFFICACY OF PREPARATIONS FOR INFLUENZA VIRUS | 2011 |
|
RU2457242C1 |
| HYDRATED N-FULLERENE-AMINO ACID DERIVATIVES, METHOD FOR PREPARING THEM AND BASED PHARMACEUTICAL COMPOSITIONS | 2011 |
|
RU2458046C1 |
| METHOD FOR BODY PROTECTION AGAINST INFECTION CAUSED BY INFLUENZA A VIRUS SUBTYPE H1N1 STRAINS WITH PREPARATION OF HUMAN ALPHA-2 INTERFERON | 2013 |
|
RU2523554C1 |
| STRAIN OF INFLUENZA VIRUS B/NOVOSIBIRSK/40/2017-MA FOR STUDYING THERAPEUTIC AND PREVENTIVE EFFICACY OF ANTIVIRAL PREPARATIONS IN VITRO AND IN VIVO | 2019 |
|
RU2703024C1 |
| ANTIVIRAL AGENT BASED ON DRY EXTRACT OF LICHEN Cetraria islandica | 2015 |
|
RU2580305C1 |
| (1S,3aR,4R,7aS)-N-(2,2,4,7a-TETRAMETHYLOCTAHYDRO-1,4-ETHANOINDENE-3a-YL)-ACETAMIDE APPLICATION AS A INFLUENZA VIRUS REPRODUCTION INHIBITOR | 2016 |
|
RU2616255C1 |
